Use of a combination of a MEK inhibitor and an ERK inhibitor for treatment of hyperproliferative diseases

The invention provides combinations comprising a MEK inhibitor (such as GDC-0973 or GDC-0623), or a pharmaceutical ly acceptable salt thereof and an ERK inhibitor (such as GDC-0994). The combinations are particularly useful for treating hyperproliferative disorders, such as cancer.

Saved in:
Bibliographic Details
Main Authors MOFFAT, JOHN, MERCHANT, MARK, BELVIN, MARCIA
Format Patent
LanguageChinese
English
Published 16.02.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention provides combinations comprising a MEK inhibitor (such as GDC-0973 or GDC-0623), or a pharmaceutical ly acceptable salt thereof and an ERK inhibitor (such as GDC-0994). The combinations are particularly useful for treating hyperproliferative disorders, such as cancer.
AbstractList The invention provides combinations comprising a MEK inhibitor (such as GDC-0973 or GDC-0623), or a pharmaceutical ly acceptable salt thereof and an ERK inhibitor (such as GDC-0994). The combinations are particularly useful for treating hyperproliferative disorders, such as cancer.
Author MOFFAT, JOHN
BELVIN, MARCIA
MERCHANT, MARK
Author_xml – fullname: MOFFAT, JOHN
– fullname: MERCHANT, MARK
– fullname: BELVIN, MARCIA
BookMark eNqNjLsKwkAQRbfQwtc_jB8gxGdqkYggNhKxDJNklgwkM8vuIvj3RrSwtDhcONx7x2YgKjQyfAsEagGh0q5kwcgqH3HJzsDScMlRPaDUPZBdf6XtiZ4wdiTxvWqejrzz2rIl3389CGoOhIHC1AwttoFm35yY-THLD6cFOS0oOKxIKBb5fZUsd8l2k6b79T-dF9XYQaQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID TW201605477A
GroupedDBID EVB
ID FETCH-epo_espacenet_TW201605477A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:15:09 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_TW201605477A3
Notes Application Number: TW20143130648
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160216&DB=EPODOC&CC=TW&NR=201605477A
ParticipantIDs epo_espacenet_TW201605477A
PublicationCentury 2000
PublicationDate 20160216
PublicationDateYYYYMMDD 2016-02-16
PublicationDate_xml – month: 02
  year: 2016
  text: 20160216
  day: 16
PublicationDecade 2010
PublicationYear 2016
RelatedCompanies F. HOFFMANN-LA ROCHE AG
RelatedCompanies_xml – name: F. HOFFMANN-LA ROCHE AG
Score 3.1372173
Snippet The invention provides combinations comprising a MEK inhibitor (such as GDC-0973 or GDC-0623), or a pharmaceutical ly acceptable salt thereof and an ERK...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Use of a combination of a MEK inhibitor and an ERK inhibitor for treatment of hyperproliferative diseases
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160216&DB=EPODOC&locale=&CC=TW&NR=201605477A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNpzLnBxGkb0W7pu36MMS1HUPZB6NzextNm9L60I21IvjXe8m6jxd9CCQXEi6BX-4ud7kAPEaGHUZ6HKs217hKWzFVWzrjqoGqrG01aWTIaML-wOxN6NvMmFXgc_MWRuYJ_ZbJERFRIeK9kOf1cneJ5crYyvyJpUhavHT9tquU1rFmosgyFbfT9kZDd-gojtP2p8pgvO4zqGW9HsAhqtGWQIP30RGvUpb7IqV7BkcjnC0rzqHyk9TgxNn8vFaD437p8MZqib38AtJJzskiJgFBTtGelVyuCX3vnaRZkjKE54oEWYSFeON9IuqmZBtULkYlaICuluLPnpivs3-T0lmTX8JD1_Odnoo8z7cbNPenu-XpV1DNFhmvA4mZTk0q0m9rAQ2bLIhCnRksbD0HNlrF9jU0_p6n8V_nDZyKhohe1sxbqBarL36Hwrlg93JXfwHV55Vc
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUaP4VROzt0XHuo09ECPbCAoDQob4RtatC_NhEDZj4l_vrYyPF31o0tylzbXJr3fXu14BHkLNDEI1imSTK1ymjYjKDZVxWUNT1jTqNNRENqHb1ztj-vahfZTgc_0WRtQJ_RbFERFRAeI9E-f1YnuJZYvcyvSRxUiaP7e9pi0V3rGio8rSJbvVdIYDe2BJltX0JlJ_tOJp1DBe9mAfTWwjR4Pz3spfpSx2VUr7GA6GOFuSnUDpZ1aFirX-ea0Kh24R8MZugb30FOJxysk8Ij5BSdGfFVKuCK7TJXEyixnCc0n8JMRGnNEuEW1Tskkqz0fN0AFdLvI_eyK-qv5NimBNegb3bcezOjLKPN1s0NSbbJennkM5mSf8AkjEVKrTvPy24tOgzvwwUJnGgsaTb6JXbF5C7e95av8x76DS8dzetPfa717BUc7IM5kV_RrK2fKL36Ciztit2OFfBCuYTw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Use+of+a+combination+of+a+MEK+inhibitor+and+an+ERK+inhibitor+for+treatment+of+hyperproliferative+diseases&rft.inventor=MOFFAT%2C+JOHN&rft.inventor=MERCHANT%2C+MARK&rft.inventor=BELVIN%2C+MARCIA&rft.date=2016-02-16&rft.externalDBID=A&rft.externalDocID=TW201605477A